Bayshore Pharms Llc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BAYSHORE PHARMS LLC, and what generic and branded alternatives to BAYSHORE PHARMS LLC drugs are available?
BAYSHORE PHARMS LLC has ten approved drugs.
Drugs and US Patents for Bayshore Pharms Llc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bayshore Pharms Llc | ETODOLAC | etodolac | TABLET, EXTENDED RELEASE;ORAL | 212263-001 | Nov 24, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Bayshore Pharms Llc | METOLAZONE | metolazone | TABLET;ORAL | 214799-001 | Mar 30, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Bayshore Pharms Llc | ETODOLAC | etodolac | TABLET;ORAL | 210704-001 | Dec 16, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Bayshore Pharms Llc | ORPHENADRINE CITRATE | orphenadrine citrate | TABLET, EXTENDED RELEASE;ORAL | 091158-001 | Jul 27, 2012 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Bayshore Pharms Llc | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | atropine sulfate; diphenoxylate hydrochloride | TABLET;ORAL | 210819-001 | Nov 13, 2018 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Bayshore Pharms Llc | KETOTIFEN FUMARATE | ketotifen fumarate | SOLUTION/DROPS;OPHTHALMIC | 204059-001 | Jun 1, 2020 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.